BBVA
TEVA icon

Banco Bilbao Vizcaya Argentaria’s Teva Pharmaceuticals TEVA Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,201
Closed -$367K – 779
2023
Q4 		$367K Buy
35,201
+594
+2% +$5.55K ﹤0.01% 669
2023
Q3 		$355K Sell
34,607
-71,298
-67% -$664K ﹤0.01% 665
2023
Q2 		$799K Buy
105,905
+40,929
+63% +$332K 0.01% 560
2023
Q1 		$574K Buy
64,976
+43,156
+198% +$427K 0.01% 597
2022
Q4 		$197K Sell
21,820
-4,630
-18% -$40.4K ﹤0.01% 701
2022
Q3 		$215K Sell
26,450
-4,985
-16% -$44.1K ﹤0.01% 698
2022
Q2 		$241K Sell
31,435
-16,734
-35% -$146K ﹤0.01% 661
2022
Q1 		$452K Sell
48,169
-70,152
-59% -$585K 0.01% 604
2021
Q4 		$948K Buy
118,321
+77,842
+192% +$703K 0.01% 584
2021
Q3 		$396K Sell
40,479
-24,037
-37% -$225K 0.01% 658
2021
Q2 		$638K Buy
64,516
+3,006
+5% +$31.8K 0.01% 589
2021
Q1 		$708K Sell
61,510
-257,800
-81% -$2.96M 0.01% 547
2020
Q4 		$3.08M Buy
319,310
+121,221
+61% +$1.16M 0.07% 243
2020
Q3 		$1.78M Sell
198,089
-19,880
-9% -$210K 0.05% 286
2020
Q2 		$2.69M Buy
217,969
+21,283
+11% +$241K 0.09% 195
2020
Q1 		$1.77M Sell
196,686
-456,117
-70% -$4.67M 0.06% 282
2019
Q4 		$6.4M Buy
+652,803
New +$5.83M 0.2% 104

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's TEVA Position: Q1 2024 in Review

Banco Bilbao Vizcaya Argentaria sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 35,201 shares — an estimated $367K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in TEVA in Q4 2019 and held it in 17 quarters. The position peaked at $6.4M in Q4 2019. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 35,201 Teva Pharmaceuticals shares in Q1 2024, an estimated $367K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Teva Pharmaceuticals in Q4 2019 and held it in 17 quarters.
  • Banco Bilbao Vizcaya Argentaria's Teva Pharmaceuticals position peaked at $6.4M in Q4 2019.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2024, filed 13 May 2024.